✦ LIBER ✦

Drotrecogin alfa (activated) should not be used in patients with severe sepsis and low risk for death

✍ Scribed by Sanjay Gupta,Eric B Milbrandt,Lakshmipathi Chelluri

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Identifying patients with severe sepsis

✍ Peter E Morris; R.Bruce Light; Gary E Garber 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Drotrecogin alfa (activated) in patients

✍ Jan O Friedrich,Neill KJ Adhikari,Maureen O Meade 📂 Article 📅 2006 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 29 KB

Introduction: rationale for using drotre

✍ Jean-François Dhainaut 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Drotrecogin alfa (activated): current ev

✍ Mark D Williams,Jonathan M Janes,David R Nelson 📂 Article 📅 2006 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 72 KB

Pharmacokinetics and Clinical Use of Dro

✍ Dr. Keith M. Olsen; Dr. Steven J. Martin 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Comprehensive safety analysis of concomi

✍ Mitchell Levy; Marcel Levi; Mark D. Williams; Massimo Antonelli; Dazhe Wang; Mar 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 183 KB